Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis

Molecular Genetics and Metabolism

Volumn 87, Issue 3 SPEC. ISS., 2006, Pages 262-271

  Kakela, Justin K ^a   Friedman, Kenneth D ^a,b   Haberichter, Sandra L ^b   Buchholz, Nadine P ^a   Christopherson, Pam A ^a   Kroner, Philip A ^b   Gill, Joan Cox ^a,b   Montgomery, Robert R ^a,b   Bellissimo, Daniel B ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

DHPLC; Mutation detection; von Willebrand disease

Indexed keywords

VON WILLEBRAND FACTOR;

ARTICLE; CLINICAL ARTICLE; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA SEQUENCE; EXON; GENE AMPLIFICATION; GENE LOCATION; GENE MUTATION; HUMAN; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

EID: 33644662851     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2005.09.016     Document Type: Article

References (32)

1. S.A. Santoro Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens Thromb. Res. 21 1981 689 691
2. H.J. Weiss von Willebrand factor and platelet function Ann. N Y Acad. Sci. 614 1991 125 137
3. J.E. Sadler Biochemistry and genetics of von Willebrand factor Annu. Rev. Biochem. 67 1998 395 424
4. H.J. Weiss, I.I. Sussman, and L.W. Hoyer Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease J. Clin. Invest. 60 1977 390 404
5. J.E. Sadler von Willebrand Disease C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Bases of Inherited Disease Vol. III 2001 The McGraw-Hill Companies New York 4415 4431
6. J.E. Sadler New concepts in von Willebrand disease Annu. Rev. Med. 56 2005 173 191
7. C. Mazurier, and D. Meyer Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease-results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thromb. Haemost. 76 1996 270 274
8. C.A. Hillery, D.J. Mancuso, S.J. Evan, J.W. Ponder, M.A. Jozwiak, P.A. Christopherson, G.J. Cox, S.J. Paul, and R.R. Montgomery Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets Blood 91 1998 1572 1581
9. P.A. Kroner, K.D. Friedman, S.A. Fahs, J.P. Scott, and R.R. Montgomery Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease J. Biol. Chem. 266 1991 19146 19149
10. P.A. Kroner, M.L. Kluessendorf, J.P. Scott, and R.R. Montgomery Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets Blood 79 1992 2048 2055
11. P.A. Kroner, P.A. Foster, S.A. Fahs, and R.R. Montgomery The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor Blood 87 1996 1013 1021
12. P.A. Kroner, and R.R. Montgomery The molecular basis of von Willebrand disease W.K. Hoots Diagnosis and Management of Severe von Willebrand Disease (Types 2 and 3) 1996 Advanstar Philadelphia 15 25
13. D.J. Mancuso, P.A. Kroner, P.A. Christopherson, E.A. Vokac, J.C. Gill, and R.R. Montgomery Type 2M: Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets Blood 88 1996 2559 2568
14. W.O. Liu, P.J. Oefner, C. Qian, R.S. Odom, and U. Francke Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders Genet. Test. 1 1997 237 242
15. W. Liu, D.I. Smith, K.J. Rechtzigel, S.N. Thibodeau, and C.D. James Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations Nucleic Acids Res. 26 1998 1396 1400
16. M.C. O'Donovan, P.J. Oefner, S.C. Roberts, J. Austin, B. Hoogendoorn, C. Guy, G. Speight, M. Upadhyaya, S.S. Sommer, and P. McGuffin Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection Genomics 52 1998 44 49
17. P.A. Underhill, L. Jin, A.A. Lin, S.Q. Mehdi, T. Jenkins, D. Vollrath, R.W. Davis, L.L. Cavalli-Sforza, and P.J. Oefner Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography Genome Res. 7 1997 996 1005
18. P.J. Oefner, P.A. Underhill, Comparative DNA sequencing by denaturing high-performance liquid chromatography (DHPLC) [abstract], Am. J. Hum. Genet. 57 (Suppl.)(1995)A266.
19. C. Eng, L.C. Brody, T.M. Wagner, P. Devilee, J. Vijg, C. Szabo, S.V. Tavtigian, K.L. Nathanson, E. Ostrander, and T.S. Frank Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1 J. Med. Genet. 38 2001 824 833
20. C. Le Marechal, M.P. Audrezet, I. Quere, O. Raguenes, S. Langonne, and C. Ferec Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling Hum. Genet. 108 2001 290 298
21. N. Arnold, H. Peper, K. Bandick, M. Kreikemeier, D. Karow, B. Teegen, and W. Jonat Establishing a control population to screen for the occurrence of nineteen unclassified variants in the BRCA1 gene by denaturing high-performance liquid chromatography J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 782 2002 99 104
22. I.M. Buyse, P. Fang, K.T. Hoon, R.E. Amir, H.Y. Zoghbi, and B.B. Roa Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms Am. J. Hum. Genet. 67 2000 1428 1436
23. G. Wu, W. Wu, M. Hegde, M. Fawkner, B. Chong, D. Love, L.K. Su, P. Lynch, K. Snow, and C.S. Richards Detection of sequence variations in the adenomatous polyposis coli (APC) gene using denaturing high-performance liquid chromatography Genet. Test. 5 2001 281 290
24. J.C. Eikenboom, H.K. Ploos van Amstel, P.H. Reitsma, and E. Briet Mutations in severe type, III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messengerRNA Thromb. Haemost. 68 1992 448 454
25. G. Narayanaswami, and P.D. Taylor Improved efficiency of mutation detection by denaturing high-performance liquid chromatography using modified primers and hybridization procedure Genet. Test. 5 2001 9 16
26. D.J. Mancuso, E.A. Tuley, L.A. Westfield, T.L. Lester-Mancuso, M.M. Le Beau, J.M. Sorace, and J.E. Sadler Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction Biochemistry 30 1991 253 269
27. R. Schneppenheim, A.B. Federici, U. Budde, G. Castaman, E. Drewke, S. Krey, P.M. Mannucci, G. Riesen, F. Rodeghiero, B. Zieger, and R. Zimmermann Von Willebrand Disease type 2M "Vicenza" in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families Thromb. Haemost. 83 2000 136 140
28. A. Veyradier, O. Dakik, J.M. Lavergne, A.S. Ribba, J.P. Girma, L. Hilbert, C. Mazurier, E. Fressinaud, D. Meyer, and the INSERM network on mo, Von Willebrand disease Vicenza with mutation R1205H of von Willebrand factor: study of 18 french patients and od recombinant VWF. [abstract]. The International Society on Thrombosis and Haemostasis (ISTH). 2001.
29. C. de Romeuf, A. Gaucher, P. Parquet, M. Baillod, C. Hanss, C. Mazurier, "Platelet discordant" types 1 and 2 von Willebrand disease may result from diminished plasma von Willibrand factor disappearance time. [abstract]. Thromb.Haemost. 1997;Abst 2681.
30. C. Gaucher, A. Parquet, M. Baillod, C. Hanss, C. Mazurier, Mutations localized in the D3 domain of von Willebrand factor are identified in patients classified in type 1 or 2A von Willebrand disease. [abstract]. Thromb.Haemost. 1997;Abst 1583.
31. Friedman K.D., Gruppo R.A., Ebert D.D., Kakela J.K., Bellissimo D.B., Endres J.L., Montgomery R.R, A Case of Compound Type 2N/Type 1 von Willebrand Disease Linked to a Novel von Willebrand Factor Exon 18 Mutation A2311G Encoding for Met 771 Val [abstract]. The International Society on Thrombosis and Haemostasis (ISTH). 2003.
32. M. Eriksson, W.T. Brown, L.B. Gordon, M.W. Glynn, J. Singer, L. Scott, M.R. Erdos, C.M. Robbins, T.Y. Moses, P. Berglund, A. Dutra, E. Pak, S. Durkin, A.B. Csoka, M. Boehnke, T.W. Glover, and F.S. Collins Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome Nature 423 2003 293 298